Strive Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- Strive Pharmacy's estimated annual revenue is currently $25.7M per year.
- Strive Pharmacy's estimated revenue per employee is $201,000
Employee Data
- Strive Pharmacy has 128 Employees.
- Strive Pharmacy grew their employee count by 110% last year.
Strive Pharmacy's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | Director Compliance | Reveal Email/Phone |
4 | Shipping assistant manager | Reveal Email/Phone |
5 | Pharmacy Manager | Reveal Email/Phone |
6 | Pharmaceutical Sales Manager | Reveal Email/Phone |
7 | Lead Instructional Designer | Reveal Email/Phone |
8 | Account Executive | Reveal Email/Phone |
9 | Pharmacy Technician | Reveal Email/Phone |
10 | Pharmaceutical Sales Executive | Reveal Email/Phone |
Strive Pharmacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.3M | 111 | 8% | N/A | N/A |
#2 | $17.7M | 88 | -19% | N/A | N/A |
#3 | $6.6M | 33 | -8% | N/A | N/A |
#4 | $29.1M | 145 | 48% | N/A | N/A |
#5 | $1.2M | 6 | -50% | N/A | N/A |
#6 | $2.2M | 11 | 10% | N/A | N/A |
#7 | $4.8M | 24 | -17% | N/A | N/A |
#8 | $34.8M | 173 | 5% | N/A | N/A |
#9 | $46.2M | 230 | 5% | N/A | N/A |
#10 | $3.2M | 16 | -11% | N/A | N/A |
What Is Strive Pharmacy?
Strive Pharmacy is Arizona's premier Sterile and Non-Sterile compounding pharmacy. Specializing in Hormone Replacement, Women's Health, Men's Health, Testosterone Replacement, Pain Management, Veterinary, and more more.
keywords:N/AN/A
Total Funding
128
Number of Employees
$25.7M
Revenue (est)
110%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.2M | 129 | 5% | N/A |
#2 | $38.6M | 133 | 5% | N/A |
#3 | $300M | 139 | 72% | N/A |
#4 | $24.8M | 141 | 37% | N/A |
#5 | $50.8M | 142 | 27% | N/A |